SEC Tracker
Get the app

Longeveron LGVN

Longeveron announces CMO departure

Form
8-K
Filed
Importance
Major
  1. Dr. Nataliya Agafonova steps down as CMO effective Oct 14, 2026
  2. Report filed Oct 14, 2026
  3. Company is emerging growth company

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Longeveron files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lipocine LPCN public float $16M, Jun 30, 2025
  2. Marker Therapeutics MRKR public float $17M, Jun 30, 2025
  3. CalciMedica CALC public float $16M, Jun 30, 2025
  4. Ernexa Therapeutics ERNA public float $18M, Jun 30, 2025
  5. Charlie's Holdings CHUC public float $18M, Jun 30, 2025